Volume 5, Issue 4

Increasing PrEP Uptake in PWID

In this issue:

People who inject drugs (PWID) are at risk for HIV infection from both sexual- as well as injection-related causes. What can clinicians do to reduce the incidence of infection and improve their patients’ health?

In this issue, Dr. Jessica Taylor from The Boston University School of Medicine and Boston Medical Center takes us into the clinic to explain how current evidence-based strategies can increase the uptake of HIV pre-exposure prophylaxis in this vulnerable population.

Learning objectives:

  • Explain appropriate screening for both injection- related and sexual-related HIV risk in people who inject drugs (or PWID) as a prelude to counseling for HIV pre-exposure prophylaxis (or PrEP).
  • Describe the barriers to PrEP uptake among PWID, and both provider-level and systems-level strategies that may improve PrEP access.

Author:

Jessica Taylor, MD
Jessica Taylor, MD

Assistant Professor, General Internal Medicine

Boston University School of Medicine

Boston, MA

Program Directors:

Ethel D. Weld, MD, PhD

Assistant Professor of Medicine and Pharmacology and Molecular Sciences
Division of Infectious Diseases
Division of Clinical Pharmacology
Johns Hopkins School of Medicine
Baltimore, Maryland

Matthew Spinelli, MD, MAS

Infectious Disease Fellow
HIV, ID, and Global Medicine
Zuckerberg San Francisco General Hospital
San Francisco, California

Justin Alves, RN, ACRN, CARN

Nurse Educator – Office Based Addiction Treatment, Training and Technical Assistance Program
Boston Medical Center
Boston, Massachusetts

Length of activity:

0.5 hour Physicians
0.5 contact hour Nurses

Launch date: March 10, 2020
Expiration date: March 9, 2022